{
  "id": 20617607,
  "title": "Pfizer Strikes Multibillion-Dollar Deal to Take on Autoimmune Diseases",
  "url": "https://urgent.news/2026/11/18/pfizer-strikes-multibillion-dollar-deal-to-take-on-autoimmune-diseases",
  "topic": "world",
  "section": "World",
  "published": "2026-11-18T15:53:02.000Z",
  "source": {
    "name": "Benzinga",
    "slug": "benzinga",
    "url": "https://www.benzinga.com/markets/biotech/26/11/63393613/pfizer-strikes-multibillion-dollar-deal-to-take-on-autoimmune-diseases"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pfizer Inc. (NYSE:PFE) announced Wednesday an exclusive licensing agreement with Starna Therapeutics worth up to $2.63 billion in upfront and milestone payments, plus royalties . The agreement expands Pfizer’s inflammation and immunology pipeline while strengthening its presence in next-generation cell therapies. Deal Terms and Financial Details Starna will receive an upfront payment of $330…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}